Skip navigation
Skip navigation

Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma

Duraiswamy, Jai; Sherritt, Martina; Thomson, Scott; Tellam, Judy; Cooper, Leanne; Connolly, Geoff; Bharadwaj, M; Khanna, Rajiv


Development of an epitope-based vaccination strategy designed to enhance Epstein-Barr virus (EBV)-specific CD8+ cytotoxic T lymphocytes (CTLs) is increasingly being considered as a preferred approach for the treatment of EBV-associated relapsed Hodgkin disease (HD) and nasopharyngeal carcinoma (NPC). EBV-encoded latent membrane proteins, LMP1 and LMP2, are the only target antigens available for therapeutic augmentation of CTL responses in patients with HD and NPC. Here, we describe preclinical...[Show more]

CollectionsANU Research Publications
Date published: 2003
Type: Journal article
Source: Blood
DOI: 10.1182/blood-2002-10-3092


File Description SizeFormat Image
01_Duraiswamy_Therapeutic_LMP1_polyepitope_2003.pdf345.14 kBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  19 May 2020/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator